CN106573952A - 己糖衍生物及其制剂和用途 - Google Patents
己糖衍生物及其制剂和用途 Download PDFInfo
- Publication number
- CN106573952A CN106573952A CN201580014386.4A CN201580014386A CN106573952A CN 106573952 A CN106573952 A CN 106573952A CN 201580014386 A CN201580014386 A CN 201580014386A CN 106573952 A CN106573952 A CN 106573952A
- Authority
- CN
- China
- Prior art keywords
- compound
- salt
- experiment
- mmol
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 *C(C(*1)S=C)OC(*)C1=O Chemical compound *C(C(*1)S=C)OC(*)C1=O 0.000 description 3
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
- C07H9/06—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing nitrogen as ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
- C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Crystallography & Structural Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Saccharide Compounds (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211044372.5A CN115448964A (zh) | 2014-03-14 | 2015-03-13 | 己糖衍生物及其制剂和用途 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461953392P | 2014-03-14 | 2014-03-14 | |
| US61/953,392 | 2014-03-14 | ||
| PCT/PT2015/050001 WO2015137838A1 (en) | 2014-03-14 | 2015-03-13 | Hexose derivatives, preparation and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202211044372.5A Division CN115448964A (zh) | 2014-03-14 | 2015-03-13 | 己糖衍生物及其制剂和用途 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106573952A true CN106573952A (zh) | 2017-04-19 |
Family
ID=53264710
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201580014386.4A Pending CN106573952A (zh) | 2014-03-14 | 2015-03-13 | 己糖衍生物及其制剂和用途 |
| CN202211044372.5A Pending CN115448964A (zh) | 2014-03-14 | 2015-03-13 | 己糖衍生物及其制剂和用途 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202211044372.5A Pending CN115448964A (zh) | 2014-03-14 | 2015-03-13 | 己糖衍生物及其制剂和用途 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11708387B2 (https=) |
| EP (1) | EP3116886A1 (https=) |
| JP (2) | JP7067867B2 (https=) |
| KR (3) | KR102651029B1 (https=) |
| CN (2) | CN106573952A (https=) |
| BR (1) | BR112016021231B1 (https=) |
| CA (1) | CA2942635C (https=) |
| IL (1) | IL247531B (https=) |
| MX (1) | MX386787B (https=) |
| RU (1) | RU2731563C2 (https=) |
| SG (2) | SG10201807891UA (https=) |
| WO (1) | WO2015137838A1 (https=) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111683957A (zh) * | 2017-11-13 | 2020-09-18 | 埃克斯特雷莫凯姆有限公司 | 作为用于生物分子的稳定剂的中性糖基化酰胺和双阴离子葡萄糖醛酸化的酸 |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102651029B1 (ko) * | 2014-03-14 | 2024-03-25 | 파쿠우다지 지 씨엔씨아스 다 우니베르시다지 지 리스보아 | 헥소스 유도체, 그의 제제 및 용도 |
| FR3061013B1 (fr) * | 2016-12-22 | 2020-04-17 | Greenpharma | Composition contenant le digeneaside, son procede d'obtention et son utilisation cosmetique, veterinaire ou nutraceutique |
| CN116251110B (zh) * | 2022-11-18 | 2025-02-14 | 广东药科大学 | β-D-吡喃葡萄糖基-乳酸及其衍生物在制备治疗代谢性疾病、炎症药物中的应用 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007097652A2 (en) * | 2006-02-24 | 2007-08-30 | STAB VIDA, Investigação e Serviços em Ciências Biológicas, Lda | Synthetic mannosylglycerate derivatives for the stabilisation and preservation of biomaterials |
| US20130143787A1 (en) * | 2010-07-27 | 2013-06-06 | Henkel Ag & Co. Kgaa | Stabilized liquid enzyme-containing surfactant preparation |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060099567A1 (en) * | 2004-04-08 | 2006-05-11 | Biomatrica, Inc. | Integration of sample storage and sample management for life science |
| DE102004031588A1 (de) * | 2004-06-30 | 2006-02-09 | Symrise Gmbh & Co. Kg | Verwendung von Äpfelsäureglucosiden als Geschmacksstoffe |
| PT103441A (pt) | 2006-02-24 | 2007-08-24 | Stab Vida Investigacao E Servi | Utilização de solutos compatíveis para melhorar o desempenho de técnicas utilizando materiais biológicos imobilizados |
| DE102011118027A1 (de) * | 2011-09-12 | 2013-03-14 | Henkel Ag & Co. Kgaa | Verfahren zur Anpassung eines Hydrolytischen Enzyms an eine das hydrolytische Enzym stabilisierende Komponente |
| KR102651029B1 (ko) | 2014-03-14 | 2024-03-25 | 파쿠우다지 지 씨엔씨아스 다 우니베르시다지 지 리스보아 | 헥소스 유도체, 그의 제제 및 용도 |
| JP2020097767A (ja) | 2018-12-18 | 2020-06-25 | 株式会社東芝 | 表面処理剤、これを用いた積層体、及び無電解めっき製品 |
-
2015
- 2015-03-13 KR KR1020227017066A patent/KR102651029B1/ko active Active
- 2015-03-13 JP JP2016575290A patent/JP7067867B2/ja active Active
- 2015-03-13 KR KR1020247009385A patent/KR102828884B1/ko active Active
- 2015-03-13 US US15/125,522 patent/US11708387B2/en active Active
- 2015-03-13 BR BR112016021231-2A patent/BR112016021231B1/pt active IP Right Grant
- 2015-03-13 KR KR1020167028609A patent/KR102401853B1/ko active Active
- 2015-03-13 SG SG10201807891UA patent/SG10201807891UA/en unknown
- 2015-03-13 MX MX2016011808A patent/MX386787B/es unknown
- 2015-03-13 CA CA2942635A patent/CA2942635C/en active Active
- 2015-03-13 CN CN201580014386.4A patent/CN106573952A/zh active Pending
- 2015-03-13 EP EP15724386.6A patent/EP3116886A1/en active Pending
- 2015-03-13 RU RU2016140337A patent/RU2731563C2/ru active
- 2015-03-13 CN CN202211044372.5A patent/CN115448964A/zh active Pending
- 2015-03-13 WO PCT/PT2015/050001 patent/WO2015137838A1/en not_active Ceased
- 2015-03-13 SG SG11201607530XA patent/SG11201607530XA/en unknown
-
2016
- 2016-08-29 IL IL247531A patent/IL247531B/en active IP Right Grant
-
2020
- 2020-06-04 JP JP2020097767A patent/JP7077361B2/ja active Active
-
2023
- 2023-06-09 US US18/332,157 patent/US12590117B2/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007097652A2 (en) * | 2006-02-24 | 2007-08-30 | STAB VIDA, Investigação e Serviços em Ciências Biológicas, Lda | Synthetic mannosylglycerate derivatives for the stabilisation and preservation of biomaterials |
| US20130143787A1 (en) * | 2010-07-27 | 2013-06-06 | Henkel Ag & Co. Kgaa | Stabilized liquid enzyme-containing surfactant preparation |
Non-Patent Citations (13)
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111683957A (zh) * | 2017-11-13 | 2020-09-18 | 埃克斯特雷莫凯姆有限公司 | 作为用于生物分子的稳定剂的中性糖基化酰胺和双阴离子葡萄糖醛酸化的酸 |
Also Published As
| Publication number | Publication date |
|---|---|
| SG11201607530XA (en) | 2016-10-28 |
| BR112016021231B1 (pt) | 2021-07-27 |
| KR102401853B1 (ko) | 2022-05-25 |
| US12590117B2 (en) | 2026-03-31 |
| JP7077361B2 (ja) | 2022-05-30 |
| US20230357301A1 (en) | 2023-11-09 |
| IL247531A0 (en) | 2016-11-30 |
| CA2942635A1 (en) | 2015-09-17 |
| KR20220153571A (ko) | 2022-11-18 |
| KR20240045328A (ko) | 2024-04-05 |
| JP2017516838A (ja) | 2017-06-22 |
| SG10201807891UA (en) | 2018-10-30 |
| EP3116886A1 (en) | 2017-01-18 |
| MX386787B (es) | 2025-03-19 |
| US20180170955A1 (en) | 2018-06-21 |
| IL247531B (en) | 2021-04-29 |
| JP2020183383A (ja) | 2020-11-12 |
| CA2942635C (en) | 2022-12-06 |
| RU2016140337A3 (https=) | 2018-10-30 |
| KR20160145584A (ko) | 2016-12-20 |
| BR112016021231A2 (en) | 2018-07-10 |
| KR102651029B1 (ko) | 2024-03-25 |
| CN115448964A (zh) | 2022-12-09 |
| US11708387B2 (en) | 2023-07-25 |
| KR102828884B1 (ko) | 2025-07-02 |
| JP7067867B2 (ja) | 2022-05-16 |
| MX2016011808A (es) | 2017-05-09 |
| RU2016140337A (ru) | 2018-04-17 |
| RU2731563C2 (ru) | 2020-09-04 |
| WO2015137838A1 (en) | 2015-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7077361B2 (ja) | ヘキソース誘導体、その製剤および使用 | |
| TWI911429B (zh) | 新穎槐糖脂質衍生物 | |
| Wang et al. | Synthesis of a suite of click-compatible sugar analogs for probing carbohydrate metabolism | |
| Karelin et al. | Synthesis of a heptasaccharide fragment of the mannan from Candida guilliermondii cell wall and its conjugate with BSA | |
| Branderhorst et al. | Synthesis of multivalent Streptococcus suis adhesion inhibitors by enzymatic cleavage of polygalacturonic acid and ‘click’conjugation | |
| Pradhan et al. | Synthesis of nonulosonic acids | |
| EP2164521A2 (fr) | Glycoconjugues et leur utilisation comme vaccin contre shigella flexneri de serotype 3a et x | |
| JP4036755B2 (ja) | ヒアルロン酸又はヒアルロン酸誘導体の製造法 | |
| Zähringer et al. | Isolation and structural characterization of a (Kdo-isosteric) d-glycero-α-d-talo-oct-2-ulopyranosidonic acid (Ko) interlinking lipid A and core oligosaccharide in the lipopolysaccharide of Acinetobacter calcoaceticus NCTC 10305 | |
| HK40084341A (en) | Hexose derivatives, preparation and uses thereof | |
| Ishiwata et al. | Intramolecular Aglycon Delivery toward 1, 2‐cis Selective Glycosylation | |
| HK1236538A1 (en) | Hexose derivatives, preparation and uses thereof | |
| Lourenço et al. | The synthesis of compatible solute analogues—solvent effects on selective glycosylation | |
| Schombs et al. | Glycochemistry: overview and progress | |
| Karelin et al. | Synthesis of a biotinylated probe from biotechnologically derived β-D-mannopyranosyl-(1→ 2)-D-mannopyranose for assessment of carbohydrate specificity of antibodies | |
| Porter | Chemical synthesis approaches to amphiphilic mimetic glycosides | |
| Muthana | Chemoenzymatic synthesis of sialic acid-containing carbohydrates | |
| Zhang | Chemical Synthesis of Fragments of Galactosaminogalactan and Pel Polysaccharides | |
| Tamura et al. | Synthesis of linear-type chondroitin clusters having a C8 spacer between disaccharide moieties and enzymatic transfer of d-glucuronic acid to the artificial glycans | |
| Qu et al. | Design, Synthesis and Bioactivity of Core 1 O-glycan and its Derivative on Human Gut Microbiota | |
| Me2S2 | 4.4 2-Iodoalkylidene Acetals as Tether | |
| Verhart | Some approaches to the innovative chemical use of sucrose and related monosaccharides | |
| Sminia | Probing the bacterial cell wall with chemical biology tools | |
| Chopra et al. | STATEMENT OF CONTRIBUTION TO CO-AUTHORED PAPER (In Communication) | |
| GLYCOSYLIERUNG | SYNTHESE VON CYCLISCHEN |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1236538 Country of ref document: HK |
|
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170419 |
|
| RJ01 | Rejection of invention patent application after publication | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1236538 Country of ref document: HK |